About Us
Cimeio Therapeutics
Cimeio is an applied gene editing and immunotherapy company developing a portfolio of Shielded-Cell & Immunotherapy Pairs™ (SCIP), which has the potential to transform hematopoietic stem cell transplant. Cimeio’s technology platform is based on the design and expression of modified variants of naturally occurring cell surface proteins in HSCs. These novel variants maintain their function but are resistant to depletion when targeted by a paired immunotherapy which has high affinity for the wild-type version of these proteins. This technology has significant therapeutic potential, which Cimeio is using to develop curative treatments for patients with genetic diseases, hematologic malignancies, and severe autoimmune disorders.
Leadership

Thomas Fuchs
Chief Executive Officer

Tristan Imbert
Chief Financial Officer

Lukas Jeker, MD/PhD
Founder, SVP Gene Editing

Daniel Stark, PhD
Chief Manufacturing Officer

Stefanie Urlinger, PhD
Chief Scientific Officer

Thomas Winkler, MD
Chief Medical Officer

Thomas Fuchs
Chief Executive Officer

Tristan Imbert
Chief Financial Officer

Lukas Jeker, MD/PhD
SVP Gene Editing

Daniel Stark, PhD
Chief Manufacturing Officer

Stefanie Urlinger, PhD
Chief Scientific Officer

Thomas Winkler, MD
Chief Medical Officer
Scientific Advisory Board

Suneet Agarwal, MD, PhD
Assoc. Prof. Harvard Medical School

Jeff Bluestone, PhD
CEO, Sonoma Bio

Toni Cathomen, MD
Prof. University of Freiburg

Corey Cutler, MD, MPH, FRCPC
Assoc. Prof. Harvard Medical School

Fyodor Urnov, PhD, Chair
Prof. University of California Berkeley

Suneet Agarwal, MD, PhD

Jeff Bluestone, PhD

Toni Cathomen, MD

Corey Cutler, MD, MPH, FRCPC

Fyodor Urnov, PhD, Chair
Board of Directors

Markus Enzelberger, Ph.D.
Independent Director

Thomas Fuchs
Chief Executive Officer

Alexander Mayweg, Ph.D.
Chairman of the Board

Luca Santarelli
Independent Director

Michael Tomsicek
Independent Director

Markus Enzelberger, Ph.D.
Independent Director

Thomas Fuchs
Chief Executive Officer

Alexander Mayweg, Ph.D.
Chairman of the Board

Luca Santarelli
Independent Director

Michael Tomsicek
Independent Director
Team

Anna Camus

Valentin Do Sacramento

Laura Garcia Prat

Eva-Maria Grossjohann

Tanja Herrmann

Andreja Knezevic

Sophie Lackner

Frank Lehmann

Rosalba Lepore

Emiel Ten Buren

Mathilde Testut

Saniye Yumlu
